<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">27955</article-id><article-id pub-id-type="doi">10.7554/eLife.27955</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology and Stem Cells</subject></subj-group></article-categories><title-group><article-title>The Calcineurin-FoxO-MuRF1 signaling pathway regulates myofibril integrity in cardiomyocytes</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-19114"><name><surname>Shimizu</surname><given-names>Hirohito</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86752"><name><surname>Langenbacher</surname><given-names>Adam D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86753"><name><surname>Huang</surname><given-names>Jie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-19122"><name><surname>Wang</surname><given-names>Kevin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86758"><name><surname>Otto</surname><given-names>Georg</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3929-948X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86755"><name><surname>Geisler</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86756"><name><surname>Wang</surname><given-names>Yibin</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-18951"><name><surname>Chen</surname><given-names>Jau-Nian</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8807-3607</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Molecular, Cell and Developmental Biology</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Genetics and Genomic Medicine</institution>, <institution>UCL Institute of Child Health</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Institute of Toxicology and Genetics</institution>, <institution>Karlsruhe Institute of Technology (KIT)</institution>, <addr-line><named-content content-type="city">Karlsruhe</named-content></addr-line>, <country>Germany</country></aff><aff id="aff4"><institution content-type="dept">Department of Anesthesiology</institution>, <institution>David Geffen School of Medicine, University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-10482"><name><surname>Yelon</surname><given-names>Deborah</given-names></name><role>Reviewing editor</role><aff><institution>University of California, San Diego</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>chenjn@mcdb.ucla.edu</email> (JC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>08</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e27955</elocation-id><history><date date-type="received"><day>20</day><month>04</month><year>2017</year></date><date date-type="accepted"><day>18</day><month>08</month><year>2017</year></date></history><permissions><copyright-statement>Â© 2017, Shimizu et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Shimizu et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-27955-v1.pdf"/><abstract><p>Altered Ca<sup>2+ </sup>handling is often present in diseased hearts undergoing structural remodeling and functional deterioration. However, whether Ca<sup>2+</sup> directly regulates sarcomere structure has remained elusive. Using a zebrafish <italic>ncx1 </italic>mutant, we explored the impacts of impaired Ca<sup>2+ </sup>homeostasis on myofibril integrity. We found that the E3 ubiquitin ligase <italic>murf1</italic> is upregulated in <italic>ncx1-</italic>deficient hearts. Intriguingly, knocking down <italic>murf1</italic> activity or inhibiting proteasome activity preserved myofibril integrity, revealing a MuRF1-mediated proteasome degradation mechanism that is activated in response to abnormal Ca<sup>2+</sup> homeostasis. Furthermore, we detected an accumulation of the <italic>murf1</italic> regulator FoxO in the nuclei of <italic>ncx1</italic>-deficient cardiomyocytes. Overexpression of FoxO in wild type cardiomyocytes induced <italic>murf1</italic> expression and caused myofibril disarray, whereas inhibiting Calcineurin activity attenuated FoxO-mediated <italic>murf1</italic> expression and protected sarcomeres from degradation in <italic>ncx1</italic>-deficient hearts. Together, our findings reveal a novel mechanism by which Ca<sup>2+</sup> overload disrupts myofibril integrity by activating a Calcineurin-FoxO-MuRF1-proteosome signaling pathway.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>HL096980</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Jau-Nian</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000780</institution-id><institution>European Commission</institution></institution-wrap></funding-source><award-id>ZF-MODELS</award-id><principal-award-recipient><name><surname>Geisler</surname><given-names>Robert</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000780</institution-id><institution>European Commission</institution></institution-wrap></funding-source><award-id>ZF-HEALTH</award-id><principal-award-recipient><name><surname>Geisler</surname><given-names>Robert</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>HL126051</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Jau-Nian</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>HL108186</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Yibin</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Nakajima Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Shimizu</surname><given-names>Hirohito</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols of the University of California, Los Angeles. The protocol was approved by the Chancellor's Animal Research Committee of the University of California, Los Angeles (ARC#2000-051-51A).</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-27955-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>